Ticker Details
ADMA Biologics Inc ADMA Biologics Inc is a biopharmaceutical company. The company develops and manufactures specialty plasma-based biologics for the proposed treatment of immune deficiencies and prevention of certain infectious diseases.
IPO Date:	October 18, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.15B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.18 | 3.01%
Avg Daily Range (30 D):	$0.22 | 2.31%
Avg Daily Range (90 D):	$0.22 | 2.43%

Institutional Daily Volume
Avg Daily Volume:	1.74M
Avg Daily Volume (30 D):	1.65M
Avg Daily Volume (90 D):	2.92M

Trade Size
Avg Trade Size (Sh.):	167
Avg Trade Size (Sh.) (30 D):	86
Avg Trade Size (Sh.) (90 D):	108

Institutional Trades
Total Institutional Trades:	2,476
Avg Institutional Trade:	$3.5M
Avg Institutional Trade (30 D):	$3.14M
Avg Institutional Trade (90 D):	$3.64M
Avg Institutional Trade Volume:	.32M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$5.88M
Avg Closing Trade (30 D):	$3.87M
Avg Closing Trade (90 D):	$5.9M
Avg Closing Volume:	531.8K

News

Aug 9, 2026 @ 3:52 PM BTU IMPORTANT DEADLINE: ROSEN, A GLOBAL AND LEADIN... Source: Rosen Law Firm

Aug 9, 2026 @ 3:41 PM ADMA DEADLINE TOMORROW: ROSEN, THE FIRST FILING FI... Source: Rosen Law Firm

Aug 7, 2026 @ 7:52 PM ADMA 3-DAY DEADLINE ALERT: ADMA Biologics, Inc. In... Source: Hagens Berman

Aug 6, 2026 @ 3:51 PM MONDAY INVESTOR DEADLINE: ADMA Biologics, Inc. Inv... Source: Robbins Geller Rudman & Dowd Llp

Aug 6, 2026 @ 1:50 PM DEADLINE ALERT for FUTU, FSLR, BRCB, ADMA: Law Off... Source: Law Offices Of Howard G. Smith

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.17	$.19	$.21
Diluted EPS	$.16	$.19	$.2
Revenue	$124.4M	$114.49M	$139.16M
Gross Profit	$86.28M	$80.75M	$88.82M
Net Income / Loss	$37.82M	$45.33M	$49.38M
Operating Income / Loss	$52.45M	$58.27M	$62.75M
Cost of Revenue	$38.12M	$33.74M	$50.35M
Net Cash Flow	$-2.13M	$50.52M	$26.25M
PE Ratio